The role of whey acidic protein four-disulfide-core proteins in respiratory health and disease

References

Alvarez, R., Reading, J., King, D.F.L., Hayes, M., Easterbrook, P., Farzaneh, F., Ressler, S., Yang, F., Rowley, D., and Vyakarnam, A. (2008). WFDC1/ps20 is a novel innate immunomodulatory signature protein of human immunodeficiency virus (HIV)-permissive CD4+ CD45RO+ memory T cells that promotes infection by upregulating CD54 integrin expression and is elevated in HIV type 1 infection. J. Virol. 82, 471–486.10.1128/JVI.00939-07Search in Google Scholar

Ameshima, S., Ishizaki, T., Demura, Y., Imamura, Y., Miyamori, I., and Mitsuhashi, H. (2000). Increased secretory leukoprotease inhibitor in patients with non small cell lung carcinoma. Cancer. 89, 1448–1456.10.1002/1097-0142(20001001)89:7<1448::AID-CNCR6>3.0.CO;2-QSearch in Google Scholar

Andelid, K., Andersson, A., Yoshihara, S., Ahren, C., Jirholt, P., Ekberg-Jansson, A., and Lindén, A. (2015). Systemic signs of neutrophil mobilization during clinically stable periods and during exacerbations in smokers with obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 10, 1253–1263.10.2147/COPD.S77274Search in Google Scholar

Assistance Publique – Hôpitaux de Paris. Biomarkers for Acute Graft-versus-host Disease (PLASMA-INCA). ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2014- [Cited 2016 July 08]. Available from: http://clinicaltrials.gov/ct2/show/NCT02254798. NLM Identifier: NCT02254798.Search in Google Scholar

Baranger, K., Zani, M-L., Chandenier, J., Dallet-Choisy, S., and Moreau, T. (2008). The antibacterial and antifungal properties of trappin-2 (pre-elafin) do not depend on its protease inhibitory function. FEBS J. 275, 2008–2020.10.1111/j.1742-4658.2008.06355.xSearch in Google Scholar

Baranger, K., Zani, M.L., Labas, V., Dallet-Choisy, S., and Moreau, T. (2011). Secretory leukocyte protease inhibitor (SLPI) is, like its homologue trappin-2 (pre-elafin), a transglutaminase substrate. PLoS One 6, e20976.10.1371/journal.pone.0020976Search in Google Scholar

Belkowski, S.M., Boot, J.D., Mascelli, M.A., Diamant, Z., de Garavilla, L., Hertzog, B., Polkovitch, D., Towers, M., Batheja, A., and D’Andrea, M.R. (2009). Cleaved secretory leucocyte protease inhibitor as a biomarker of chymase activity in allergic airway disease. Clin. Exp. Allergy. 39, 1179–1186.10.1111/j.1365-2222.2009.03247.xSearch in Google Scholar

Bingle, C.D. and Vyakarnam, A. (2008). Novel innate immune functions of the whey acidic protein family. Trends. Immunol. 29, 444–453.10.1016/j.it.2008.07.001Search in Google Scholar

Bingle, L., Tetley, T.D., and Bingle, C.D. (2001). Cytokine-mediated induction of the human elafin gene in pulmonary epithelial cells is regulated by nuclear factor-kappaB. Am. J. Respir. Cell. Mol. Biol. 25, 84–91.10.1165/ajrcmb.25.1.4341Search in Google Scholar

Bingle, L., Singleton, V., and Bingle, C.D. (2002). The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms. Oncogene. 21, 2768–2773.10.1038/sj.onc.1205363Search in Google Scholar

Bingle, L., Cross, S.S., High, A.S., Wallace, W.A., Rassl, D., Yuan, G., Hellstrom, I., Campos, M.A., and Bingle, C.D. (2006). WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung. Respir. Res. 7, 61.10.1186/1465-9921-7-61Search in Google Scholar

Boston Medical Center. Vaginal Innate Immunity in Normal and HIV-Infected Women. ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2010- [Cited 2016 July 08]. Available from: http://clinicaltrials.gov/ct2/show/NCT01318304. NLM Identifier: NCT01318304.Search in Google Scholar

Boudier, C. and Bieth, J.G. (1992). The proteinase: mucus proteinase inhibitor binding stoichiometry. J. Biol. Chem. 267, 4370–4375.10.1016/S0021-9258(18)42845-1Search in Google Scholar

Brown, A., Farmer, K., MacDonald, L., Kalsheker, N., Pritchard, D., Haslett, C., Lamb, J., and Sallenave, J.M. (2003). House dust mite Der p 1 downregulates defenses of the lung by inactivating elastase inhibitors. Am. J. Respir. Cell. Mol. Biol. 29, 381–389.10.1165/rcmb.2003-0060OCSearch in Google Scholar PubMed

Butler, M.W., Robertson, I., Greene, C.M., O’Neill, S.J., Taggart, C.C., and McElvaney, N.G. (2006). Elafin prevents lipopolysaccharide-induced AP-1 and NF-kappaB activation via an effect on the ubiquitin-proteasome pathway. J. Biol. Chem. 281, 34730–34735.10.1074/jbc.M604844200Search in Google Scholar PubMed

Camper, N., Glasgow, A.M.A., Osbourn, M., Quinn, D.J., Small, D.M., McLean, D.T., Lundy, F.T., Elborn, J.S., McNally, P., Ingram, R.J., et al. (2016). A secretory leukocyte protease inhibitor variant with improved activity against lung infection. Mucosal Immunology. 9, 669–676.10.1038/mi.2015.90Search in Google Scholar PubMed

Center for International Blood and Marrow Transplant Research. Collaborators: Pediatric Blood and Marrow Transplant Consortium. National Marrow Donor Program. Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies. ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2015- [Cited 2016 July 08]. Available from: http://clinicaltrials.gov/ct2/show/NCT02338479. NLM Identifier: NCT02338479.Search in Google Scholar

Cheng, D., Sun, Y., and He, H. (2015). The diagnostic accuracy of HE4 in lung cancer: a meta-analysis. Dis. Markers. 2015, 352670.10.1155/2015/352670Search in Google Scholar PubMed PubMed Central

Chhikara, N., Saraswat, M., Tomar, A.K., Dey, S., Singh, S., and Yadav, S. (2012). Human epididymis protein-4 (HE-4): a novel cross-class protease inhibitor. PLoS One 7, e47672.10.1371/journal.pone.0047672Search in Google Scholar PubMed PubMed Central

Choy, C. and Kim, S-H. (2010). Biological actions and interactions of anosmin-1. Front. Horm. Res. 39, 78–93.10.1159/000312695Search in Google Scholar PubMed

Clauss, A., Lilja, H., and Lundwall, A. (2002). A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein. Biochem. J. 368, 233–242.10.1042/bj20020869Search in Google Scholar PubMed PubMed Central

Clauss, A., Persson, M., Lilja, H., and Lundwall, A. (2011). Three genes expressing Kunitz domains in the epididymis are related to genes of WFDC-type protease inhibitors and semen coagulum proteins in spite of lacking similarity between their protein products. BMC Biochem. 12, 55.10.1186/1471-2091-12-55Search in Google Scholar PubMed PubMed Central

Curvelo, J.A., Barreto, A.L., Portela, M.B., Alviano, D.S., Holandino, C., Souto-Padron, T., and Soares, R.M. (2014). Effect of the secretory leucocyte proteinase inhibitor (SLPI) on Candida albicans biological processes: a therapeutic alternative? Arch. Oral Biol. 59, 928–937.10.1016/j.archoralbio.2014.05.007Search in Google Scholar PubMed

Cutting, G.R. (2015). Cystic fibrosis genetics: from molecular understanding to clinical application. Nat. Rev. Genet. 16, 45–56.10.1038/nrg3849Search in Google Scholar

Daccord, C. and Maher, T.M. (2016). Recent advances in understanding idiopathic pulmonary fibrosis. F1000Res. 5, (F1000 Faculty Rev):1046.10.12688/f1000research.8209.1Search in Google Scholar

Desai, M. and Oppenheimer, J. (2016). Elucidating asthma phenotypes and endotypes: progress towards personalized medicine. Ann. Allergy. Asthma. Immunol. 116, 394–401.10.1016/j.anai.2015.12.024Search in Google Scholar

Devoogdt, N., Hassanzadeh Ghassabeh, G., Zhang, J., Brys, L., De Baetselier, P., and Revets, H. (2003). Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells. Proc. Natl. Acad. Sci. 100, 5778–5782.10.1073/pnas.1037154100Search in Google Scholar

Devoogdt, N., Revets, H., Kindt, A., Liu, Y.Q., De Baetselier, P., and Ghassabeh, G.H. (2006). The tumor-promoting effect of TNF-alpha involves the induction of secretory leukocyte protease inhibitor. J. Immunol. 177, 8046–8052.10.4049/jimmunol.177.11.8046Search in Google Scholar

Dougherty, R.H. and Fahy, J.V. (2009). Acute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype. Clin. Exp. Allergy. 39, 193–202.10.1111/j.1365-2222.2008.03157.xSearch in Google Scholar

Draijer, C., Hylkema, M.N., Boorsma, C.E., Klok, P.A., Robbe, P., Timens, W., Postma, D.S., Greene, C.M., and Melgert, B.N. (2016). Sexual maturation protects against development of lung inflammation through estrogen. Am. J. Physiol. Lung. Cell. Mol. Physiol. 310, 166–174.10.1152/ajplung.00119.2015Search in Google Scholar

Drannik, A.G., Henrick, B.M., and Rosenthal, K.L. (2011). War and peace between WAP and HIV: role of SLPI, trappin-2, elafin and ps20 in susceptibility to HIV infection. Biochem. Soc. Trans. 39, 1427–1432.10.1042/BST0391427Search in Google Scholar

Drannik, A.G., Nag, K., Sallenave, J.M., and Rosenthal, K.L. (2013). Antiviral activity of trappin-2 and elafin in vitro and in vivo against genital herpes. J. Virol. 87, 7526–7538.10.1128/JVI.02243-12Search in Google Scholar

Drenth, J., Low, B.W., Richardson, J.S., and Wright, C.S. (1980). The toxin-agglutinin fold. A new group of small protein structures organized around a four-disulfide core. J. Biol. Chem. 255, 2652–2655.10.1016/S0021-9258(19)85783-6Search in Google Scholar

Eisenberg, S.P., Hale, K.K., Heimdal, P., and Thompson, R.C. (1990). Location of the protease-inhibitory region of secretory leukocyte protease inhibitor. J. Biol. Chem. 265, 7976–7981.10.1016/S0021-9258(19)39026-XSearch in Google Scholar

Escudero, J.M., Auge, J.M., Filella, X., Torne, A., Pahisa, J., and Molina, R. (2011). Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and non-malignant diseases. Clin. Chem. 57, 1534–1544.10.1373/clinchem.2010.157073Search in Google Scholar PubMed

Farady, C.J. and Craik, C.S. (2010). Mechanisms of Macromolecular Protease Inhibitors. Chem. BioChem. 11, 2341–2346.10.1002/cbic.201000442Search in Google Scholar PubMed PubMed Central

Ferreira, Z., Seixas, S., Andrés, A.M., Kretzschmar, W.W., Mullikin, J.C., Cherukuri, P.F., Cruz, P., Swanson, W.J., Clark, A.G., Green, E.D., et al. (2013). Reproduction and immunity-driven natural selection in the human WFDC locus. Mol. Biol. Evol. 30, 938–950.10.1093/molbev/mss329Search in Google Scholar PubMed PubMed Central

Foreman, M.G., Campos, M., and Celedón, J.C. (2012). Genes and chronic obstructive pulmonary disease. Med. Clin. North Am. 96, 699–711.10.1016/j.mcna.2012.02.006Search in Google Scholar PubMed PubMed Central

Francart, C., Dauchez, M., Alix, A.J., and Lippens, G. (1997). Solution structure of R-elafin, a specific inhibitor of elastase. J. Mol. Biol. 268, 666–677.10.1006/jmbi.1997.0983Search in Google Scholar PubMed

Galgano, M.T., Hampton, G.M., and Frierson, H.F. (2006). Comprehensive analysis of HE4 expression in normal and malignant human tissues. Mod. Pathol. 19, 847–853.10.1038/modpathol.3800612Search in Google Scholar PubMed

Geraghty, P. Rogan, M.P., Greene, C.M., Brantly, M.L., O’Neill, S.J., Taggart, C.C., and McElvaney, N.G. (2008). Alpha-one antitrypsin aerosolized augmentation abrogates neutrophil elastase induced expression of Cathepsin B and Matrix Metalloprotease 2 in vivo and in vitro. Thorax. 63, 621–626.10.1136/thx.2007.088559Search in Google Scholar PubMed

Glasgow, A.M.A., Small, D.M., Scott, A., McLean, D.T., Camper, N., Hamid, U., Hegarty, S., Parekh, D., O’Kane, C., Lundy, F.T., et al. (2015). A role for whey acidic protein four-disulfide-core 12 (WFDC12) in the regulation of the inflammatory response in the lung. Thorax. 70, 426–432.10.1136/thoraxjnl-2014-206488Search in Google Scholar PubMed

Gompertz, S., Bayley, D.L., Hill, S.L., and Stockley, R.A. (2001). Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD. Thorax. 56, 36–41.10.1136/thorax.56.1.36Search in Google Scholar PubMed PubMed Central

Grutter, M.G., Fendrich, G., Huber, R., and Bode, W. (1988). The 2.5 A X-ray crystal structure of the acid-stable proteinase inhibitor from human mucous secretions analysed in its complex with bovine alpha-chymotrypsin. EMBO J. 7, 345–351.10.1002/j.1460-2075.1988.tb02819.xSearch in Google Scholar PubMed PubMed Central

Guyot, N., Zani, M.-L., Maurel, M-C., Dallet-Choisy, S., and Moreau, T. (2005). Elafin and its precursor trappin-2 still inhibit neutrophil serine proteinases when they are covalently bound to extracellular matrix proteins by tissue transglutaminase. Biochemistry 44, 15610–15618.10.1021/bi051418iSearch in Google Scholar PubMed

Guyot, N., Butler, M.W., McNally, P., Weldon, S., Greene, C.M., Levine, R.L., O’Neill, S.J., Taggart, C.C., and McElvaney, N.G. (2008). Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis. J. Biol. Chem. 283, 32377–32385.10.1074/jbc.M803707200Search in Google Scholar PubMed PubMed Central

Habgood, A.N., Tatler, A.L., Porte, J., Wahl, S.M., Laurent, G.J., John, A.E., Johnson, S.R., and Jenkins, G. (2016). Secretory leukocyte protease inhibitor gene deletion alters bleomycin-induced lung injury, but not the development of pulmonary fibrosis. Labor. Invest. 96, 623–631.10.1038/labinvest.2016.40Search in Google Scholar PubMed PubMed Central

Hagiwara, K., Kikuchi, T., Endo, Y., Huqun, Usui, K., Takahashi, M., Shibata, N., Kusakabe, T., Xin, H., Hoshi, S., et al. (2003). Mouse SWAM1 and SWAM2 are antibacterial proteins composed of a single whey acidic protein motif. J. Immunol. 170, 1973–1979.10.4049/jimmunol.170.4.1973Search in Google Scholar PubMed

Hellström, I., Raycraft, J., Hayden-Ledbetter, M., Ledbetter, J.A., Schummer, M., McIntosh, M., Drescher, C., Urban, N., and Hellström, K.E. (2003). The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res. 63, 3695–3700.Search in Google Scholar

Hiemstra, P.S., Maassen, R.J., Stolk, J., Heinzel-Wieland, R., Steffens, G.J., and Dijkman, J.H. (1996). Antibacterial activity of antileukoprotease. Infect. Immun. 64, 4520–4524.10.1128/iai.64.11.4520-4524.1996Search in Google Scholar PubMed PubMed Central

Hocini, H., Becquart, P., Bouhlal, H., Adle-Biassette, H., Kazatchkine, M.D., and Belec, L. (2000). Secretory leukocyte protease inhibitor inhibits infection of monocytes and lymphocytes with human immunodeficiency virus type 1 but does not interfere with transcytosis of cell-associated virus across tight epithelial barriers. Clin. Diagn. Lab. Immunol. 7, 515–518.10.1128/CDLI.7.3.515-518.2000Search in Google Scholar PubMed PubMed Central

Hollander, C., Sitkauskiene, B., Sakalauskas, R., Westin, U., and Janciauskiene, S.M. (2007). Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma. Respir. Med. 101, 1947–1953.10.1016/j.rmed.2007.04.010Search in Google Scholar PubMed

Hua, L., Liu, Y., Zhen, S., Wan, D., Cao, J., and Gao, X. (2014). Expression and biochemical characterization of recombinant human epididymis protein 4. Protein Expr. Purif. 102, 52–62.10.1016/j.pep.2014.08.004Search in Google Scholar PubMed

Hurle, B., Swanson, W., and Green, E.D. (2007). Comparative sequence analyses reveal rapid and divergent evolutionary changes of the WFDC locus in the primate lineage. Genome Res. 17, 276–286.10.1101/gr.6004607Search in Google Scholar PubMed PubMed Central

Icahn School of Medicine at Mount Sinai. Secukinumab for Treatment of Atopic Dermatitis. ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2015- [Cited 2016 July 08]. Available from: http://clinicaltrials.gov/ct2/show/NCT02594098. NLM Identifier: NCT02594098.Search in Google Scholar

Imai, F.L., Uzawa, K., Miyakawa, A., Shiiba, M., and Tanzawa, H. (2001). A detailed deletion map of chromosome 20 in human oral squamous cell carcinoma. Int. J. Mol. Med. 7, 43–47.10.3892/ijmm.7.1.43Search in Google Scholar

Imperial College London. Collaborator: AstraZeneca. GR Defect in Sputum Cells in COPD. ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2005- [Cited 2016 July 08]. Available from: http://clinicaltrials.gov/ct2/show/NCT00159276. NLM Identifier: NCT00159276.Search in Google Scholar

Iwahori, K., Suzuki, H., Kishi, Y., Fujii, Y., Uehara, R., Okamoto, N., Kobayashi, M., Hirashima, T., Kawase, I., and Naka, T. (2012). Serum HE4 as a diagnostic and prognostic marker for lung cancer. Tumour Biol. 33, 1141–1149.10.1007/s13277-012-0356-9Search in Google Scholar

James, H.L. and Cohen, A.B. (1978). Mechanism of inhibition of porcine elastase by human alpha-1-antitrypsin. J. Clin. Invest. 62, 1344–1353.10.1172/JCI109255Search in Google Scholar

Jan Treda, C., Fukuhara, T., Suzuki, T., Nakamura, A., Zaini, J., Kikuchi, T., Ebina, M., and Nukiwa, T. (2014). Secretory leukocyte protease inhibitor modulates urethane-induced lung carcinogenesis. Carcinogenesis 35, 896–904.10.1093/carcin/bgt382Search in Google Scholar

Jin, F.Y., Nathan, C., Radzioch, D., and Ding, A. (1997). Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 88, 417–426.10.1016/S0092-8674(00)81880-2Search in Google Scholar

Jin, F., Nathan, C.F., Radzioch, D., and Ding, A. (1998). Lipopolysaccharide-related stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophage-derived lipopolysaccharide inhibitor. Infect. Immun. 66, 2447–2452.10.1128/IAI.66.6.2447-2452.1998Search in Google Scholar PubMed PubMed Central

Kamei, M., Yamashita, S.-I., Tokuishi, K., Hashioto, T., Moroga, T., Suehiro, S., Ono, K., Miyawaki, M., Takeno, S., Yamamoto, S., et al. (2010). HE4 expression can be associated with lymph node metastases and disease-free survival in breast cancer. Anticancer Res. 30, 4779–4783.Search in Google Scholar

Kammouni, W., Figarella, C., Baeza, N., Marchand, S., and Merten, M.D. (1997). Pseudomonas aeruginosa lipopolysaccharide induces CF-like alteration of protein secretion by human tracheal gland cells. Biochem. Biophys. Res. Commun. 241, 305–311.10.1006/bbrc.1997.7720Search in Google Scholar PubMed

Kerrin, A., Weldon, S., Chung, A.H., Craig, T., Simpson, A.J., O’Kane, C.M., McAuley, D.F., and Taggart, C.C. (2013). Proteolytic cleavage of elafin by 20S proteasome may contribute to inflammation in acute lung injury. Thorax. 68, 315–321.10.1136/thoraxjnl-2012-202536Search in Google Scholar PubMed

Kikuchi, T., Abe, T., Hoshi, S., Matsubara, N., Tominaga, Y., Satoh, K., and Nukiwa T. (1998). Structure of the murine secretory leukoprotease inhibitor (Slpi) gene and chromosomal localization of the human and murine SLPI genes. Am. J. Respir. Cell. Mol. Biol. 19, 875–880.10.1165/ajrcmb.19.6.3314Search in Google Scholar PubMed

Kirchhoff, C., Habben, I., Ivell, R., and Krull, N. (1991). A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors. Biol. Reprod. 45, 350–357.10.1095/biolreprod45.2.350Search in Google Scholar PubMed

Kondás, K., Szláma, G., Trexler, M., and Patthy, L. (2008). Both WFIKKN1 and WFIKKN2 have high affinity for growth and differentiation factors 8 and 11. J. Biol. Chem. 283, 23677–23684.10.1074/jbc.M803025200Search in Google Scholar

Krowarsch, D., Cierpicki, T., Jelen, F., and Otlewski, J. (2003). Canonical protein inhibitors of serine proteases. Cell. Mol. Life Sci. 60, 2427–2444.10.1007/s00018-003-3120-xSearch in Google Scholar

Lamy, P.-J., Plassot, C., and Pujol, J.-L. (2015). Serum HE4: an independent prognostic factor in non-small cell lung cancer. PLoS One 10, e0128836.10.1371/journal.pone.0128836Search in Google Scholar

Larsen, M., Ressler, S.J., Lu, B., Gerdes, M.J., McBride, L., Dang, T.D., and Rowley, D.R. (1998). Molecular cloning and expression of ps20 growth inhibitor. A novel WAP-type “four-disulfide core” domain protein expressed in smooth muscle. J. Biol. Chem. 273, 4574–4584.10.1074/jbc.273.8.4574Search in Google Scholar

Laurell, C.B. and Eriksson, S. (1963). The electrophoretic α;1-globulin pattern of serum in α;1-antitrypsin deficiency. Scand. J. Clin. Lab. Invest. 15, 132–140.10.1080/00365516309051324Search in Google Scholar

LeBleu, V.S., Teng, Y., O’Connell, J.T., Charytan, D., Müller, G.A., Müller, C.A., Sugimoto, H., and Kalluri, R. (2013). Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis. Nat. Med. 19, 227–231.10.1038/nm.2989Search in Google Scholar

Lentsch, A.B., Jordan, J.A., Czermak, B.J., Diehl, K.M., Younkin, E.M., Sarma, V., and Ward, P.A. (1999). Inhibition of NF-kappaB activation and augmentation of IkappaBbeta by secretory leukocyte protease inhibitor during lung inflammation. Am. J. Pathol. 154, 239–247.10.1016/S0002-9440(10)65270-4Search in Google Scholar

Liu, W., Yang, J., Chi, P.-D., Zheng, X., Dai, S.-Q., Chen, H., Xu, B.-L., and Liu, W.-L. (2013). Evaluating the clinical significance of serum HE4 levels in lung cancer and pulmonary tuberculosis. Int. J. Tuberc. Lung Dis. 17, 1346–1353.10.5588/ijtld.13.0058Search in Google Scholar PubMed

Lundwall, Å. and Clauss, A. (2002). Identification of a novel protease inhibitor gene that is highly expressed in the prostate. Biochem. Biophys. Res. Commun. 290, 452–456.10.1006/bbrc.2001.6224Search in Google Scholar PubMed

Lundwall, Å. and Clauss, A. (2011). Genes encoding WFDC- and Kunitz-type protease inhibitor domains: are they related? Biochem. Soc. Trans. 39, 1398–1402.10.1042/BST0391398Search in Google Scholar PubMed

Majchrzak-Gorecka, M., Majewski, P., Grygier, B., Murzyn, K., and Cichy, J. (2015). Secretory leukocyte protease inhibitor (SLPI), a multifunctional protein in the host defense response. Cytokine Growth Factor Rev. 28, 79–93.10.1016/j.cytogfr.2015.12.001Search in Google Scholar

Mallia, P., Footitt, J., Sotero, R., Jepson, A., Contoli, M., Trujillo-Torralbo, M.-B., Kebadze, T., Aniscenko, J., Oleszkiewicz, G., Gray, K., et al. (2012). Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 186, 1117–1124.10.1164/rccm.201205-0806OCSearch in Google Scholar

Marino, R., Thuraisingam, T., Camateros, P., Kanagaratham, C., Xu, Y.Z., Henri, J., Yang, J., He, G., Ding, A., Radzioch, D. (2011). Secretory leukocyte protease inhibitor plays an important role in the regulation of allergic asthma in mice. J. Immunol. 186, 4433–4442.10.4049/jimmunol.1001539Search in Google Scholar

McCrudden, M.T.C., Dafforn, T.R., Houston, D.F., Turkington, P.T., and Timson, D.J. (2008). Functional domains of the human epididymal protease inhibitor, eppin. FEBS J. 275, 1742–1750.10.1111/j.1742-4658.2008.06333.xSearch in Google Scholar

McElvaney, N.G., Nakamura, H., Birrer, P., Hébert, C.A., Wong, W.L., Alphonso, M., Baker, J.B., Catalano, M.A., and Crystal, R.G. (1992). Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor. J Clin Invest. 90, 1296–1301.10.1172/JCI115994Search in Google Scholar

McNeely, T.B., Dealy, M., Dripps, D.J., Orenstein, J.M., Eisenberg, S.P., and Wahl, S.M. (1995). Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J. Clin. Invest. 96, 456–464.10.1172/JCI118056Search in Google Scholar

Meyer-Hoffert, U., Wichmann, N., Schwichtenberg, L., White, P.C., and Wiedow, O. (2003). Supernatants of Pseudomonas aeruginosa induce the Pseudomonas-specific antibiotic elafin in human keratinocytes. Exp. Dermatol. 12, 418–425.10.1034/j.1600-0625.2002.120409.xSearch in Google Scholar

Michelland, S., Gazzeri, S., Brambilla, E., and Robert-Nicoud, M. (1999). Comparison of chromosomal imbalances in neuroendocrine and non-small-cell lung carcinomas. Cancer Genet. Cytogenet. 114, 22–30.10.1016/S0165-4608(99)00035-7Search in Google Scholar

Mihaila, A. and Tremblay, G.M. (2001). Human alveolar macrophages express elafin and secretory leukocyte protease inhibitor. Z. Naturforsch. C. 56, 291–297.10.1515/znc-2001-3-420Search in Google Scholar PubMed

Mikami, Y., Iwase, T., Komiyama, Y., Matsumoto, N., Oki, H., and Komiyama, K. (2015). Secretory leukocyte protease inhibitor inhibits expression of polymeric immunoglobulin receptor via the NF-kappaB signaling pathway. Mol. Immunol. 67, 568–574.10.1016/j.molimm.2015.07.021Search in Google Scholar PubMed

Miller, K.W., Evans, R.J., Eisenberg, S.P., and Thompson, R.C. (1989). Secretory leukocyte protease inhibitor binding to mRNA and DNA as a possible cause of toxicity to Escherichia coli. J. Bacteriol. 171, 2166–2172.10.1128/jb.171.4.2166-2172.1989Search in Google Scholar

Mitsuhashi, H., Asano, S., Nonaka, T., Hamamura, I., Masuda, K., and Kiyoki, M. (1996). Administration of truncated secretory leukoprotease inhibitor ameliorates bleomycin-induced pulmonary fibrosis in hamsters. Am. J. Respir. Crit. Care. Med. 153, 369–374.10.1164/ajrccm.153.1.8542145Search in Google Scholar

Molhuizen, H.O., Alkemade, H.A., Zeeuwen, P.L., de Jongh, G.J., Wieringa, B., and Schalkwijk, J. (1993). SKALP/elafin: an elastase inhibitor from cultured human keratinocytes. Purification, cDNA sequence, and evidence for transglutaminase cross-linking. J. Biol. Chem. 268, 12028–12032.10.1016/S0021-9258(19)50303-9Search in Google Scholar

Müller, U., Hentschel, J., Janhsen, W.K., Hunniger, K., Hipler, U.C., Sonnemann, J., Pfister, W., Böer, K., Lehmann, T., and Mainz, J.G. (2015). Changes of proteases, antiproteases, and pathogens in cystic fibrosis patients’ upper and lower airways after IV-antibiotic therapy. Mediators Inflamm. 2015, 626530.10.1155/2015/626530Search in Google Scholar PubMed PubMed Central

Nagy, A., Trexler, M., Patthy, L. (2003). Expression, purification and characterization of the second Kunitz-type protease inhibitor domain of the human WFIKKN protein. Eur. J. Biochem. 270, 2101–2107.10.1046/j.1432-1033.2003.03593.xSearch in Google Scholar PubMed

Nagy, B., Fila, L., Clarke, L.A., Gönczy, F., Bede, O., Nagy, D., Újhelyi, R., Szabó, Á., Anghelyi, A., Major, M., et al. (2016). Human epididymis protein 4 (HE4): a novel serum inflammatory biomarker in cystic fibrosis. Chest 150, 661–672.10.1016/j.chest.2016.04.006Search in Google Scholar PubMed

Nara, K., Ito, S., Ito, T., Suzuki, Y., Ghoneim, M.A., Tachibana, S., and Hirose, S. (1994). Elastase inhibitor elafin is a new type of proteinase inhibitor which has a transglutaminase-mediated anchoring sequence termed “cementoin. J. Biochem. 115, 441–448.10.1093/oxfordjournals.jbchem.a124357Search in Google Scholar PubMed

National Institute of Dental and Craniofacial Research (NIDCR). Effects of Topical SLPI on Skin Wounds. ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000- [Cited 2016 July 08]. Available from: http://clinicaltrials.gov/ct2/show/NCT00005569. NLM Identifier: NCT00005569.Search in Google Scholar

Oboki, K., Ohno, T., Kajiwara, N., Arae, K., Morita, H., Ishii, A., Nambu, A., Abe, T., Kiyonari, H., and Matsumoto, K. (2010). IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc Natl Acad Sci. 107, 18581–18586.10.1073/pnas.1003059107Search in Google Scholar PubMed PubMed Central

O’Neal, R.L., Nam, K.T., LaFleur, B.J., Barlow, B., Nozaki, K., Lee, H-J., Kim, W.H., Yang, H-K., Shi, C., Maitra, A., et al. (2013). Human epididymis protein 4 is up-regulated in gastric and pancreatic adenocarcinomas. Hum. Pathol. 44, 734–742.10.1016/j.humpath.2012.07.017Search in Google Scholar PubMed PubMed Central

Orfanelli, T., Jayaram, A., Doulaveris, G., Forney, L.J., Ledger, W.J., and Witkin, S.S. (2014). Human epididymis protein 4 and secretory leukocyte protease inhibitor in vaginal fluid: relation to vaginal components and bacterial composition. Reprod. Sci. 21, 538–542.10.1177/1933719113503416Search in Google Scholar PubMed PubMed Central

Pant, S., Walters, E.H., Griffiths, A., Wood-Baker, R., Johns, D.P., and Reid, D.W. (2009). Airway inflammation and anti-protease defences rapidly improve during treatment of an acute exacerbation of COPD. Respirology 14, 495–503.10.1111/j.1440-1843.2009.01517.xSearch in Google Scholar

Petryszak, R., Keays, M., Tang, Y.A., Fonseca, N.A., Barrera, E., Burdett, T., Füllgrabe, A., Fuentes, A.M.-P., Jupp, S., Koskinen, S., et al. (2016). Expression Atlas update – an integrated database of gene and protein expression in humans, animals and plants. Nucleic Acids Res. 44, D746–D752.10.1093/nar/gkv1045Search in Google Scholar

Pfundt, R., Wingens, M., Bergers, M., Zweers, M., Frenken, M., and Schalkwijk, J. (2000). TNF-alpha and serum induce SKALP/elafin gene expression in human keratinocytes by a p38 MAP kinase-dependent pathway. Arch. Dermatol. Res. 292, 180–187.10.1007/s004030050475Search in Google Scholar

Piletz, J.E., Heinlen, M., and Ganschow, R.E. (1981). Biochemical characterization of a novel whey protein from murine milk. J. Biol. Chem. 256, 11509–11516.10.1016/S0021-9258(19)68430-9Search in Google Scholar

Proteo Incorporated (Inc). R&D news, Clinical development [Internet]. Available from: http://proteo.us/proteo-inc/r-und-d/clinical-development.html. Accessed 2016 July 08.Search in Google Scholar

Ranganathan, S., Simpson, K.J., Shaw, D.C., and Nicholas, K.R. (1999). The whey acidic protein family: a new signature motif and three-dimensional structure by comparative modeling. J. Mol. Graph. Model. 17, 106–113.10.1016/S1093-3263(99)00023-6Search in Google Scholar

Rao, N.V., Wehner, N.G., Marshall, B.C., Gray, W.R., Gray, B.H., and Hoidal, J.R. (1991). Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional properties. J. Biol. Chem. 266, 9540–9548.10.1016/S0021-9258(18)92854-1Search in Google Scholar

Raundhal, M., Morse, C., Khare, A., Oriss, T.B., Milosevic, J., Trudeau, J., Huff, R., Pilewski, J., Holguin, F., Kolls, J., et al. (2015). High IFN-gamma and low SLPI mark severe asthma in mice and humans. J. Clin. Invest. 125, 3037–3050.10.1172/JCI80911Search in Google Scholar PubMed PubMed Central

Ressler, S.J. and Rowley, D.R. (2011). The WFDC1 gene: role in wound response and tissue homoeostasis. Biochem. Soc. Trans. 39, 1455–1459.10.1042/BST0391455Search in Google Scholar PubMed

Rohde, G., Message, S.D., Haas, J.J., Kebadze, T., Parker, H., Laza-Stanca, V., Khaitov, M.R., Kon, O.M., Stanciu, L.A., Mallia, P., et al. (2014). CXC chemokines and antimicrobial peptides in rhinovirus-induced experimental asthma exacerbations. Clin. Exp. Allergy. 44, 930–939.10.1111/cea.12313Search in Google Scholar PubMed PubMed Central

Rudolphus, A., Heinzel-Wieland, R., Vincent, V.A.M.M., Saunders, D., Steffens, G.J., Dijkman, J.H., and Kramps, J.A. (1991). Oxidation-resistant variants of recombinant anti-leucoprotease are better inhibitors of human-neutrophil-elastase-induced emphysema in hamsters than natural recombinant antileucoprotease. Clin. Sci. 81, 777–784.10.1042/cs0810777Search in Google Scholar PubMed

Sagel, S.D., Wagner, B.D., Anthony, M.M., Emmett. P., and Zemanick, E.T. (2012). Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis. Am. J. Respir. Crit. Care. Med. 186, 857–865.10.1164/rccm.201203-0507OCSearch in Google Scholar

Sallenave, J.M. and Silva, A. (1993). Characterization and gene sequence of the precursor of elafin, an elastase-specific inhibitor in bronchial secretions. Am. J. Respir. Cell. Mol. Biol. 8, 439–445.10.1165/ajrcmb/8.4.439Search in Google Scholar

Sallenave, J.M., Marsden, M.D., and Ryle, A.P. (1992). Isolation of elafin and elastase-specific inhibitor (ESI) from bronchial secretions. Evidence of sequence homology and immunological cross-reactivity. Biol. Chem. Hoppe. Seyler. 373, 27–33.10.1515/bchm3.1992.373.1.27Search in Google Scholar

Sallenave, J.M., Shulmann, J., Crossley, J., Jordana, M., and Gauldie, J. (1994). Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am. J. Respir. Cell Mol. Biol. 11, 733–741.10.1165/ajrcmb.11.6.7946401Search in Google Scholar

Sallenave, J.M., Donnelly, S.C., Grant, I.S., Robertson, C., Gauldie, J., and Haslett, C. (1999). Secretory leukocyte proteinase inhibitor is preferentially increased in patients with acute respiratory distress syndrome. Eur. Respir. J. 13, 1029–1036.10.1183/09031936.99.13510299Search in Google Scholar

Schalkwijk, J., Chang, A., Janssen, P., De Jongh, G.J., and Mier, P.D. (1990). Skin-derived antileucoproteases (SKALPs): characterization of two new elastase inhibitors from psoriatic epidermis. Br. J. Dermatol. 122, 631–641.10.1111/j.1365-2133.1990.tb07285.xSearch in Google Scholar

Schalkwijk, J., de Roo, C., and de Jongh, G.J. (1991). Skin-derived antileukoproteinase (SKALP), an elastase inhibitor from human keratinocytes. Purification and biochemical properties. Biochim. Biophys. Acta. 1096, 148–154.10.1016/0925-4439(91)90053-CSearch in Google Scholar

Schalkwijk, J., Wiedow, O., and Hirose, S. (1999). The trappin gene family: proteins defined by an N-terminal transglutaminase substrate domain and a C-terminal four-disulphide core. Biochem. J. 340, 569–577.10.1042/bj3400569Search in Google Scholar

Schummer, M., Ng, W.V, Bumgarner, R.E., Nelson, P.S., Schummer, B., Bednarski, D.W., Hassell, L., Baldwin, R.L., Karlan, B.Y., and Hood, L. (1999). Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas. Gene. 238, 375–385.10.1016/S0378-1119(99)00342-XSearch in Google Scholar

Sham, J.S.T., Tang, TC-M., Fang, Y., Sun, L., Qin, L-X., Wu, Q-L., Xie, D., and Guan, X-Y. (2002). Recurrent chromosome alterations in primary ovarian carcinoma in Chinese women. Cancer Genet. Cytogenet. 133, 39–44.10.1016/S0165-4608(01)00567-2Search in Google Scholar

Sigrist, C.J.A., de Castro, E., Cerutti, L., Cuche, B.A., Hulo, N., Bridge, A., Bougueleret, L., and Xenarios, I. (2013). New and continuing developments at PROSITE. Nucleic Acids Res. 41, D344–D347.10.1093/nar/gks1067Search in Google Scholar

Simpson, A.J., Maxwell, A.I., Govan, J.R., Haslett, C., and Sallenave, J.M. (1999). Elafin (elastase-specific inhibitor) has anti-microbial activity against gram-positive and gram-negative respiratory pathogens. FEBS Lett. 452, 309–313.10.1016/S0014-5793(99)00670-5Search in Google Scholar

Simpson, J.L., Scott, R.J., Boyle, M.J., and Gibson, P.G. (2005). Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma. Am. J. Respir. Crit. Care. Med. 172, 559–565.10.1164/rccm.200503-369OCSearch in Google Scholar PubMed

Small, D.M., Zani, M-L., Quinn, D.J., Dallet-Choisy, S., Glasgow, A.M., O’Kane, C., McAuley, D.F., McNally, P., Weldon, S., Moreau, T., et al. (2015). A functional variant of elafin with improved anti-inflammatory activity for pulmonary inflammation. Mol. Ther. 1, 24–31.10.1038/mt.2014.162Search in Google Scholar PubMed PubMed Central

Stockley, R.A. (2015). The multiple facets of alpha-1-antitrypsin. Ann. Transl. Med. 3, 130.Search in Google Scholar

Sugino, T., Yamaguchi, T., Ogura, G., Kusakabe, T., Goodison, S., Homma, Y., and Suzuki, T. (2007). The secretory leukocyte protease inhibitor (SLPI) suppresses cancer cell invasion but promotes blood-borne metastasis via an invasion-independent pathway. J. Pathol. 212, 152–160.10.1002/path.2156Search in Google Scholar PubMed PubMed Central

Taggart, C.C., Lowe, G.J., Greene, C.M., Mulgrew, A.T., O’Neill, S.J., Levine, R.L., and McElvaney, N.G. (2001). Cathepsin B, L, and S cleave and inactivate secretory leucoprotease inhibitor. J. Biol. Chem. 276, 33345–33352.10.1074/jbc.M103220200Search in Google Scholar PubMed

Taggart, C.C., Greene, C.M., McElvaney, N.G., and O’Neill, S. (2002). Secretory leucoprotease inhibitor prevents lipopolysaccharide-induced IkappaBalpha degradation without affecting phosphorylation or ubiquitination. J. Biol. Chem. 277, 33648–33653.10.1074/jbc.M203710200Search in Google Scholar PubMed

Taggart, C.C., Cryan, S.A., Weldon, S., Gibbons, A., Greene, C.M., Kelly, E., Low, T.B., O’Neill, S.J., and McElvaney, N.G. (2005). Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding. J. Exp. Med. 202, 1659–1668.10.1084/jem.20050768Search in Google Scholar PubMed PubMed Central

Tanner, M.M., Tirkkonen, M., Kallioniemi, A., Isola, J., Kuukasjarvi, T., Collins, C., Kowbel, D., Guan, X.-Y., Trent, J., Gray, J.W., et al. (1996). Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in guman breast cancer. Cancer Res. 56, 3441–3445.Search in Google Scholar

Tateosian, N.L., Costa, M.J., Guerrieri, D., Barro, A., Mazzei, J.A., and Eduardo Chuluyan, H. (2012). Inflammatory mediators in exhaled breath condensate of healthy donors and exacerbated COPD patients. Cytokine. 58, 361–367.10.1016/j.cyto.2012.03.006Search in Google Scholar PubMed

Tejera, P., Wang, Z., Zhai, R., Su, L., Sheu, C.C., Taylor, D.M., Chen, F., Gong, M.N., Thompson, B.T., and Christiani, D.C. (2009). Genetic polymorphisms of peptidase inhibitor 3 (elafin) are associated with acute respiratory distress syndrome. Am. J. Respir. Cell. Mol. Biol. 41, 696–704.10.1165/rcmb.2008-0410OCSearch in Google Scholar PubMed PubMed Central

Tejera, P., O’Mahony, D.S., Owen, C.A., Wei, Y., Wang, Z., Gupta, K., Su, L., Villar, J., Wurfel, M., and Christiani, D.C. (2014). Functional characterization of polymorphisms in the peptidase inhibitor 3 (elafin) gene and validation of their contribution to risk of acute respiratory distress syndrome. Am. J. Respir. Cell. Mol. Biol. 51, 262–272.10.1165/rcmb.2013-0238OCSearch in Google Scholar

Thompson, R.C. and Ohlsson, K. (1986). Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc. Natl. Acad. Sci. 83, 6692–6696.10.1073/pnas.83.18.6692Search in Google Scholar

Tokuishi, K., Yamashita, S., Ohbo, K., and Kawahara, K. (2012). Splice variant HE4-V3 expression is associated with favorable prognosis in pulmonary adenocarcinoma. Tumour Biol. 33, 103–109.10.1007/s13277-011-0252-8Search in Google Scholar

Tomee, J.F., Hiemstra, P.S., Heinzel-Wieland, R., and Kauffman, H.F. (1997). Antileukoprotease: an endogenous protein in the innate mucosal defense against fungi. J. Infect. Dis. 176, 740–747.10.1086/514098Search in Google Scholar

Tsoumakidou, M., Bouloukaki, I., Thimaki, K., Tzanakis, N., and Siafakas, N.M. (2010) Innate immunity proteins in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Exp Lung Res. 36, 373–380.10.3109/01902141003690389Search in Google Scholar

Tsunemi, M., Kato, H., Nishiuchi, Y., Kumagaye, S., and Sakakibara, S. (1992). Synthesis and structure-activity relationships of elafin, an elastase-specific inhibitor. Biochem. Biophys. Res. Commun. 185, 967–973.10.1016/0006-291X(92)91721-2Search in Google Scholar

Verrier, T., Solhonne, B., Sallenave, J.-M., and Garcia-Verdugo, I. (2012). The WAP protein Trappin-2/Elafin: a handyman in the regulation of inflammatory and immune responses. Int. J. Biochem. Cell Biol. 44, 1377–1380.10.1016/j.biocel.2012.05.007Search in Google Scholar PubMed

Vos, J.B., van Sterkenburg, M.A., Rabe, K.F., Schalkwijk, J., Hiemstra, P.S., and Datson, N.A. (2005). Transcriptional response of bronchial epithelial cells to Pseudomonas aeruginosa: identification of early mediators of host defense. Physiol. Genomics. 21, 324–336.10.1152/physiolgenomics.00289.2004Search in Google Scholar PubMed

Wagenblast, E., Soto, M., Gutierrez-Angel, S., Hartl, C.A., Gable, A.L., Maceli, A.R., Erard, N., Williams, A.M., Kim, S.Y., Dickopf, S., et al. (2015). A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis. Nature. 520, 358–362.10.1038/nature14403Search in Google Scholar PubMed PubMed Central

Wang, Z., Beach, D., Su, L., Zhai, R., and Christiani, D.C. (2008). A genome-wide expression analysis in blood identifies pre-elafin as a biomarker in ARDS. Am. J. Respir. Cell. Mol. Biol. 38, 724–732.10.1165/rcmb.2007-0354OCSearch in Google Scholar PubMed PubMed Central

Wang, Z., Chen, F., Zhai, R., Zhang, L., Su, L., Lin, X., Thompson, T., and Christiani D.C. (2009). Plasma neutrophil elastase and elafin imbalance is associated with acute respiratory distress syndrome (ARDS) development. PLoS One 4, e4380.10.1371/journal.pone.0004380Search in Google Scholar PubMed PubMed Central

Weldon, S., McNally, P., McElvaney, N.G., Elborn, J.S., McAuley, D.F., Wartelle, J., Belaaouaj, A., Levine, R.L., and Taggart, C.C. (2009). Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation. J. Immunol. 183, 8148–8156.10.4049/jimmunol.0901716Search in Google Scholar

Wenzel, S.E. (2012). Asthma phenotypes: the evolution from clinical to molecular approaches. Nat. Med. 18, 716–725.10.1038/nm.2678Search in Google Scholar

Westin, U., Nyström, M., Ljungcrantz, I., Eriksson, B., and Ohlsson, K. (2002). The presence of elafin, SLPI, IL1-RA and STNFalpha RI in head and neck squamous cell carcinomas and their relation to the degree of tumour differentiation. Mediators Inflamm. 11, 7–12.10.1080/09629350210304Search in Google Scholar

Wiedow, O., Schröder, J.M., Gregory, H., Young, J.A., and Christophers, E. (1990). Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence. J. Biol. Chem. 265, 14791–14795.10.1016/S0021-9258(18)77182-2Search in Google Scholar

Wiedow, O., Lüademann, J., and Utecht, B. (1991). Elafin is a potent inhibitor of proteinase 3. Biochem. Biophys. Res. Commun. 174, 6–10.10.1016/0006-291X(91)90476-NSearch in Google Scholar

Williams, S.E., Brown, T.I., Roghanian, A., and Sallenave, J.M. (2006). SLPI and elafin: one glove, many fingers. Clin. Sci. (Lond). 110, 21–35.10.1042/CS20050115Search in Google Scholar PubMed

Yadam, S., Bihler, E., and Balaan, M. (2016). Acute Respiratory Distress Syndrome. Crit. Care. Nurs. Q. 39, 190–195.10.1097/CNQ.0000000000000111Search in Google Scholar PubMed

Yenugu, S., Richardson, R.T., Sivashanmugam, P., Wang, Z., O’rand, M.G., French, F.S., and Hall, S.H. (2004). Antimicrobial activity of human EPPIN, an androgen-regulated, sperm-bound protein with a whey acidic protein motif. Biol. Reprod. 71, 1484–1490.10.1095/biolreprod.104.031567Search in Google Scholar PubMed

Yoshida, N., Egami, H., Yamashita, J., Takai, E., Tamori, Y., Fujino, N., Kitaoka, M., Schalkwijk, J., and Ogawa, M. (2002). Immunohistochemical expression of SKALP/elafin in squamous cell carcinoma of human lung. Oncol. Rep. 9, 495–501.10.3892/or.9.3.495Search in Google Scholar

Zani, M.-L., Baranger, K., Guyot, N., Dallet-Choisy, S., and Moreau, T. (2009). Protease inhibitors derived from elafin and SLPI and engineered to have enhanced specificity towards neutrophil serine proteases. Protein Sci. 18, 579–594.10.1002/pro.64Search in Google Scholar PubMed PubMed Central

Zeeuwen, P.L., Hendriks, W., de Jong, W.W., and Schalkwijk, J. (1997). Identification and sequence analysis of two new members of the SKALP/elafin and SPAI-2 gene family. Biochemical properties of the transglutaminase substrate motif and suggestions for a new nomenclature. J. Biol. Chem. 272, 20471–20478.10.1074/jbc.272.33.20471Search in Google Scholar PubMed

Zelvyte, I., Wallmark, A., Piitulainen, E., Westin, U., and Janciauskiene, S. (2004). Increased plasma levels of serine proteinase inhibitors in lung cancer patients. Anticancer Res. 24, 241–247.Search in Google Scholar

Zhu, H., Lam, D.C.L., Han, K.C., Tin, V.P.C., Suen, W.S., Wang, E., Lam, W.K., Cai. W.W., Chung, L.P., and Wong, M.P. (2007). High resolution analysis of genomic aberrations by metaphase and array comparative genomic hybridization identifies candidate tumour genes in lung cancer cell lines. Cancer Lett. 245, 303–314.10.1016/j.canlet.2006.01.020Search in Google Scholar PubMed